序号 |
标题 |
次数 |
作者 |
发布时间 |
66331 |
Sulfhydryl Reactive Liposomes,巯基反应脂质体 |
76 |
axc |
2024-12-20 |
66332 |
cas:100462-73-5,diethyl 7-bromoheptylphosphonate,7-溴庚基二膦酸二乙酯 |
65 |
kx |
2024-12-20 |
66333 |
Propargyl-PEG2-CH2COOH,丙炔基-二聚乙二醇-乙酸 |
62 |
wyh |
2024-12-20 |
66334 |
Mal-amido-PEG8-val-gly-PAB-OH - CAS 2353409-52-4 |
71 |
zyl |
2024-12-20 |
66335 |
DBCO-PEG4-Val-Ala-PAB-PNP,CAS号:2348405-93-4 |
83 |
WYQ |
2024-12-20 |
66336 |
Metal Chelating Liposomes,金属螯合脂质体 |
71 |
axc |
2024-12-20 |
66337 |
HS-PEG10-CH2CH2COOH,硫基十聚乙二醇丙酸 |
146 |
wyh |
2024-12-20 |
66338 |
cas:1446282-24-1,[10-(Diethoxy-phosphoryl)-decyl]-phosphonic acid,抗体药物偶联物(ADC) |
114 |
kx |
2024-12-20 |
66339 |
Folate Liposomes,叶酸脂质体 |
121 |
axc |
2024-12-20 |
66340 |
MC-Val-Cit-Doxorubicin ,CAS号:159857-70-2 |
57 |
WYQ |
2024-12-20 |
66341 |
alpha-GalNAc-TEG-Alkyne,丙-2-炔氧基乙氧基)乙氧基)乙氧基)-2-乙酰氨基-2脱氧-α-D-吡喃半乳糖苷 |
117 |
wyh |
2024-12-20 |
66342 |
Azido-PEG4-Val-Ala-PAB的结构式 |
116 |
zyl |
2024-12-20 |
66343 |
cas:5943-17-9,Tetraethyl heptane-1,7-diylbis(phosphonate), ADC试剂 |
62 |
kx |
2024-12-20 |
66344 |
Fmoc-PEG2-Val-Cit-PAB-OH |
108 |
zyl |
2024-12-20 |
66345 |
TCO-PEG3-CH2-aldehyde,环辛烯-三聚乙二醇-CH2-醛基 |
67 |
wyh |
2024-12-20 |
66346 |
cas:59156-70-6,Di(N-succinimidyl)adipate,己二酸 1,6-二(2,5-二氧代-1-吡咯烷基)酯 |
72 |
kx |
2024-12-20 |
66347 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
80 |
zyl |
2024-12-20 |
66348 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF详细信息 |
77 |
WYQ |
2024-12-20 |
66349 |
FMOC-N-甲基-三聚乙二醇-丙酸,Fmoc-N-methyl-PEG3-CH2CH2COOH |
73 |
wyh |
2024-12-20 |
66350 |
cas:98627-69-1,1,3-Bis-aminooxy propane,1,3-双氨基氧基丙烷 |
63 |
kx |
2024-12-20 |
66351 |
m-PEG7-CH2CH2COOH,1093647-41-6 |
86 |
wyh |
2024-12-20 |
66352 |
NHS ester-PEG4-VC-PAB-PBD |
69 |
zyl |
2024-12-20 |
66353 |
cas:894096-02-7,β-D-triacetylglucopyranosiduronyl methyl ester-phenol-β-Alanine, ADC试剂 |
64 |
kx |
2024-12-20 |
66354 |
Alloc-Val-Ala-PAB(CAS号:1343407-91-9) |
65 |
WYQ |
2024-12-20 |
66355 |
VH032-NH-CO-CH2-NHBoc,2010986-19-1 |
65 |
wyh |
2024-12-20 |
66356 |
Alloc-Val-Ala-OH(CAS号:330970-70-2) |
105 |
WYQ |
2024-12-20 |
66357 |
DBCO Reactive Liposomes,DBCO反应性脂质体 |
57 |
axc |
2024-12-20 |
66358 |
1714123-51-9,Tetrazine-biotin,生物素标记四嗪 |
55 |
kx |
2024-12-20 |
66359 |
MC-Val-Ala-OH(CAS号:1895916-22-9) |
107 |
WYQ |
2024-12-20 |
66360 |
Carboxylic Acid Reactive Liposomes,羧酸反应性脂质体 |
60 |
axc |
2024-12-20 |
66361 |
Tetrazine-C5-NHS, 四嗪-C5-N-羟基琥珀酰亚胺酯,抗体药物偶联物(ADC) |
95 |
kx |
2024-12-20 |
66362 |
Mal-PEG8-Val-Cit-PAB-MMAE(CAS号:2353409-69-3) |
66 |
WYQ |
2024-12-20 |
66363 |
Biotinylated Liposomes 生物素化脂质体 |
73 |
axc |
2024-12-20 |
66364 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAE(CAS号:2762519-08-2) |
59 |
WYQ |
2024-12-20 |
66365 |
MC-VC-PAB-DMAE-Etoposide的介绍 |
63 |
zyl |
2024-12-20 |
66366 |
DBCO-PEG4-Val-Cit-PAB-MMAE(CAS号:2129164-91-4) |
65 |
WYQ |
2024-12-20 |
66367 |
Azide Reactive Liposomes 叠氮反应性脂质体 |
74 |
axc |
2024-12-20 |
66368 |
Tetrazine-SS-NHS,四嗪-二硫键-羟基琥珀酰亚胺酯, ADC试剂 |
55 |
kx |
2024-12-20 |
66369 |
Amine Reactive Liposomes 胺反应性脂质体 |
88 |
axc |
2024-12-20 |
66370 |
BCN-PEG4-vc-PAB-MMAF的结构式 |
85 |
zyl |
2024-12-20 |
66371 |
BCN-PEG3-Val-Cit-PFP Ester, CAS号:2353409-45-5 |
85 |
WYQ |
2024-12-20 |
66372 |
Azido-PEG3-Val-Cit-PAB-PNP,CAS号:2055047-18-0 |
66 |
WYQ |
2024-12-20 |
66373 |
DOPG:DOPC (1:99)阴离子脂质体 DOPG:DOPC (0.5:99.5) Anionic Liposomes |
92 |
axc |
2024-12-20 |
66374 |
Azido-PEG3-Val-Cit-PAB-OH, CAS号:2055024-65-0 |
61 |
WYQ |
2024-12-20 |
66375 |
DBCO-PEG4-GGFG-DX8951 抗体-药物偶联物(ADC) |
85 |
zyl |
2024-12-20 |